In our work, the combined HR for 17 studies evaluating the correlation between K-ras mutations and overall survival of patients with pancreatic cancer was 1.51 (95 % CI 1.32–1.72, P = 0.000), which indicated that K-ras mutations have negative prognostic value in pancreatic cancer. Here, KRAS is linked to pancreatic neoplasm.